cell transcriptome analysis (Broad Clinical Labs)
96
Structured Review
Broad Clinical Labs
cell transcriptome analysis
Cell Transcriptome Analysis, supplied by Broad Clinical Labs, used in various techniques. Bioz Stars score: 96/100, based on 883 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+transcriptome+sequencing+analysis/Single+Cell+Sequencing/pmc12075640__41467_2025_59695_MOESM1_ESM-709-1-14
Average 96 stars, based on 883 article reviews
Cell Transcriptome Analysis, supplied by Broad Clinical Labs, used in various techniques. Bioz Stars score: 96/100, based on 883 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+transcriptome+sequencing+analysis/Single+Cell+Sequencing/pmc12075640__41467_2025_59695_MOESM1_ESM-709-1-14
Average 96 stars, based on 883 article reviews
cell transcriptome analysis - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Single Cell:Article Title: Discovery of a MUC3B gene reconstructs the membrane mucin gene cluster on human chromosome 7. Article Snippet: .. Single-cell expression of transcription factors Expression profiles for transcription factors were extracted from the following data sets available at Single Cell Portal (Broad institute): Article Title: Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS) Article Snippet: .. For Expressing:Article Title: Discovery of a MUC3B gene reconstructs the membrane mucin gene cluster on human chromosome 7. Article Snippet: .. Single-cell expression of transcription factors Expression profiles for transcription factors were extracted from the following data sets available at Single Cell Portal (Broad institute): RNA Sequencing:Article Title: Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS) Article Snippet: .. For Sequencing:Article Title: Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS) Article Snippet: .. For Next-Generation Sequencing:Article Title: Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS) Article Snippet: .. For |